1998
DOI: 10.1016/s0360-3016(98)80315-5
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia and metallothionein expression in squamous cell carcinomas of the cervix or head and neck using pimonidazole as a marker of tumor hypoxia at the cellular level

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Microscopically, tumor hypoxia can be detected by immunohistochemistry staining of biopsies or tumor slices (Raleigh et al 1998), where hypoxic cells are visualized using exogenous bio-reductive markers such as pimonidazole or EF5. Immunohistochemistry staining has been used as a physiological reference to assess hypoxia tracer uptake in autoradiography and the results of kinetic modeling in preclinical studies (Cho et al 2009, Troost et al 2008.…”
Section: Introductionmentioning
confidence: 99%
“…Microscopically, tumor hypoxia can be detected by immunohistochemistry staining of biopsies or tumor slices (Raleigh et al 1998), where hypoxic cells are visualized using exogenous bio-reductive markers such as pimonidazole or EF5. Immunohistochemistry staining has been used as a physiological reference to assess hypoxia tracer uptake in autoradiography and the results of kinetic modeling in preclinical studies (Cho et al 2009, Troost et al 2008.…”
Section: Introductionmentioning
confidence: 99%